Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    n/a
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    n/a

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 1 year

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	Trend
Assets
Cash and Cash Equivalents	—
Short Term Investments	—
Accounts Receivable	—
Inventory	—
Prepaid Expenses	—
Other Current Assets	—
Total Current Assets	—
Property,Plant and Equipment	—
Operating Lease Assets	—
Goodwill	—
Intangible Assets	—
Long Term Investments	—
Other Noncurrent Assets	—
Total Assets	—
Liabilities
Accounts Payable	—
Accrued Liabilities	—
Deferred Revenue	—
Current Portion of Long Term Debt	—
Total Current Liabilities	—
Long Term Debt	—
Deferred Revenue Noncurrent	—
Other Noncurrent Liabilities	—
Total Liabilities	—
Equity
Preferred Stock	—
Common Stock	—
Additional Paid In Capital	—
Retained Earnings	—
Treasury Stock	—
Accumulated Other Comprehensive Income	—
Total Stockholders Equity	—
Total Liabilitiesand Equity	—

Income Statement

Revenue, expense, and profitability

20 accounts · 1 year

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	—
Expenses Cost of Revenue	—
Expenses Research and Development	—
Expenses Selling,General and Administrative	—
Expenses Depreciation and Amortization	—
Expenses Share Based Compensation	—
Expenses Restructuring and Asset Impairment	—
Expenses Operating Expenses	—
Other Income Expense Operating Income	—
Other Income Expense Interest Income	—
Other Income Expense Interest Expense	—
Other Income Expense Other Income/expense	—
Other Income Expense Income Before Tax	—
Income Tax Income Tax Expense	—
net Income net Income	—
net Income Comprehensive Income	—
Earnings Per Share Basic Eps	—
Earnings Per Share Diluted Eps	—
Earnings Per Share Weighted Average Shares Basic	—
Earnings Per Share Weighted Average Shares Diluted	—

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 1 year

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	Trend
CashFlow
Operating Activities net Income	—
Operating Activities Depreciation and Amortization	—
Operating Activities Stock Based Compensation	—
Operating Activities Deferred Income Taxes	—
Operating Activities Changes In Operating Assets and Liabilities	—
Operating Activities net Cash From Operating Activities	—
Investing Activities Capital Expenditures	—
Investing Activities Business Acquisitions	—
Investing Activities Purchases of Investments	—
Investing Activities net Cash From Investing Activities	—
Financing Activities Proceeds From Debt	—
Financing Activities Repayment of Debt	—
Financing Activities Repurchase of Common Stock	—
Financing Activities Dividends Paid	—
Financing Activities Proceeds From Stock Issuance	—
Financing Activities Tax Withholding On Stock Based Compensation	—
Financing Activities Other Financing Activities	—
Financing Activities net Cash From Financing Activities	—
Cash Reconciliation Effect of Exchange Rate On Cash	—
Cash Reconciliation net Change In Cash	—
Cash Reconciliation Cash At Beginning of Period	—
Cash Reconciliation Cash At End of Period	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	+52.4%
Operating margin	+21.3%
Net margin	+18.8%
FCF margin	+16.6%
Growth
Revenue CAGR (3y)	+0.5%
Returns
ROE	+19.3%
ROA	+10.2%
ROIC	+16.2%
Liquidity
Current ratio	1.96x
Quick ratio	1.40x
Leverage
D/E	0.89x
Interest coverage	13.21x
Efficiency
Asset turnover	0.55x
Cash conversion cycle	+128d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched